DDInter1526 DDInter1147
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from *Neisseria meningitidis* serogroup C. *N. meningitidis* is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
Procarbazine {u} (Compound) resembles {v} (Compound) Atenolol
Procarbazine {u} (Compound) treats {v} (Disease) hematologic cancer
Procarbazine {u} (Compound) binds {v} (Gene) CYP1B1
Procarbazine {u} (Compound) upregulates {v} (Gene) MOK
Procarbazine {u} (Compound) is included by {v} (Pharmacologic Class) Alkylating Activity
Procarbazine {u} (Compound) downregulates {v} (Gene) DLD
Procarbazine {u} (Compound) causes {v} (Side Effect) Headache
Procarbazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cinoxacin
Procarbazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Delafloxacin
Procarbazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Guanadrel
Procarbazine (Compound) resembles Atenolol (Compound)
Procarbazine (Compound) treats hematologic cancer (Disease)
Procarbazine (Compound) binds CYP1B1 (Gene)
Procarbazine (Compound) upregulates MOK (Gene)
Procarbazine (Compound) is included by Alkylating Activity (Pharmacologic Class)
Procarbazine (Compound) downregulates DLD (Gene)
Procarbazine (Compound) causes Headache (Side Effect)
Procarbazine may cause a minor interaction that can limit clinical effects when taken with Cinoxacin
Procarbazine may cause a minor interaction that can limit clinical effects when taken with Delafloxacin
Procarbazine may cause a moderate interaction that could exacerbate diseases when taken with Guanadrel